Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
02/26/1998 | CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
02/26/1998 | CA2235148A1 Novel dnas and process for producing proteins by using the same |
02/25/1998 | EP0825442A2 Morphogenic protein screening method |
02/25/1998 | EP0825260A2 Arginase II |
02/25/1998 | EP0825259A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp |
02/25/1998 | EP0825194A2 An amide derivative of amythiamicin |
02/25/1998 | EP0824918A1 REMEDY AND PREVENTIVE FOR DISEASES CAUSED BY NF-$g(k)B |
02/25/1998 | EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque |
02/25/1998 | EP0824699A2 Compounds and methods for diagnosis of leishmaniasis |
02/25/1998 | EP0824593A2 Engineering protein posttranslational modification in transgenic organisms |
02/25/1998 | EP0824589A1 Utrophin gene promoter |
02/25/1998 | EP0824588A1 Il-6 activity inhibitor |
02/25/1998 | EP0824586A1 Human uridine diphosphate galactose-4-epimerase |
02/25/1998 | EP0824583A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
02/25/1998 | EP0824547A1 Anti-fungal peptides |
02/25/1998 | EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use |
02/25/1998 | EP0824545A1 Peptide compositions with growth factor-like activity |
02/25/1998 | EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
02/25/1998 | EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use |
02/25/1998 | EP0824357A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
02/25/1998 | EP0824352A1 Cyclodextrin compounds and methods of making and use thereof |
02/25/1998 | EP0824346A2 Use of sesquiterpenes for inhibiting oxidative enzymes |
02/25/1998 | EP0721447B1 Anthracene derivatives for use as anticancer agent or dye |
02/25/1998 | EP0711304B1 Nickel-free hemoglobin and methods for producing such hemoglobin |
02/25/1998 | EP0590070B1 Broad spectrum antimicrobial compounds and methods of use |
02/25/1998 | EP0563222B1 Biologically active bactericidal/permeability-increasing protein fragments |
02/25/1998 | EP0500695B1 GnRH ANALOGS |
02/25/1998 | CN1174575A Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
02/25/1998 | CN1174573A Human vascular IBP-like growth factor |
02/25/1998 | CN1174572A Human tissue inhibitor of metalloproteinase -4 |
02/25/1998 | CN1174513A Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
02/25/1998 | CN1174512A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
02/25/1998 | CN1174509A Gene transfer-mediated angiogenesis therapy |
02/25/1998 | CN1174508A Improvement in or relating to endometrial function |
02/25/1998 | CN1174507A Antitumor agent potentiator comprising IL-6 antagonist |
02/25/1998 | CN1174504A Piperidines, pyrrolidines and hexahydro -1H -azepines promote release of growth hormone |
02/25/1998 | CN1174493A Amelioration of human erectile dysfunction by treatment with iNOS, and related NOS agents |
02/25/1998 | CN1174082A Method of using active peptide in strengthening animal's immunity and as vaccine adjuvant |
02/24/1998 | US5721354 For treatment of infections, medical diagnosis |
02/24/1998 | US5721353 DNAs coding for LCU13 ! motilin |
02/24/1998 | US5721351 Compositions and methods for the treatment and diagnosis of immune disorders |
02/24/1998 | US5721349 Genetically altered mutant strain |
02/24/1998 | US5721348 DNA encoding PH-20 proteins |
02/24/1998 | US5721340 p53 proteins with altered tetramerization domains |
02/24/1998 | US5721338 Inhibitors of oligosaccharyl transferase |
02/24/1998 | US5721337 Human thymosin β15 |
02/24/1998 | US5721251 Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone |
02/24/1998 | US5721250 Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
02/24/1998 | US5721244 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
02/24/1998 | US5721222 Inhibitors of human leukocyte elastase |
02/24/1998 | US5721215 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
02/24/1998 | US5721214 Inhibitors of factor Xa |
02/24/1998 | US5721213 Peptides, active as inhibitors of platelet aggregation |
02/24/1998 | US5721212 Peptides for heparin and low molecular weight heparin anticoagulation reversal |
02/24/1998 | US5721211 Compositions and methods for treating small cell and nonsmall cell lung cancers |
02/24/1998 | US5721210 Cyclic cell adhesion modulation compounds |
02/24/1998 | US5721208 Glycopeptides a process for their preparation and their use |
02/24/1998 | US5721207 Administering elcatonin in acceptable vehicle by intrathecal route |
02/24/1998 | US5721206 Stimulating the eye cell growth with interferons; preventing eye disease and degradation |
02/24/1998 | US5721122 Obtaining lymphocytes |
02/24/1998 | US5721121 Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein |
02/24/1998 | US5721119 Nucleic acid sequences |
02/24/1998 | US5721110 Reacting autoimmune antigen (from genetically engineered cells) with autoimmune antibody(from test sample) to form a complex which can be identified |
02/24/1998 | US5721108 Capable of mediating antibody-dependent cellular cytotoxicity or complement-dependent cytolysis |
02/24/1998 | US5721107 Antibodies to G protein coupled glutamate receptors |
02/24/1998 | US5721104 Screening assay for anti-HIV drugs |
02/24/1998 | US5720957 Recombinant human cytomegalovirus vaccine |
02/24/1998 | US5720955 Method of treating rheumatoid arthritis with soluble collagen |
02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
02/24/1998 | US5720952 Administering colony stimulating factor |
02/24/1998 | US5720937 In vivo tumor detection assay |
02/24/1998 | CA2002208C Extraction methods for preparing thromboplastin reagents |
02/23/1998 | CA2183901A1 Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans |
02/23/1998 | CA2183900A1 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
02/22/1998 | CA2213057A1 An amide derivative of amythiamicin |
02/19/1998 | WO1998006871A1 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma |
02/19/1998 | WO1998006864A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
02/19/1998 | WO1998006861A2 Delivery of tolerogenic antigens via edible plants or plant-derived products |
02/19/1998 | WO1998006859A1 Human chitinase alpha and chitinase alpha-2 |
02/19/1998 | WO1998006851A2 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF $i(MORAXELLA CATARRHALIS) |
02/19/1998 | WO1998006849A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
02/19/1998 | WO1998006847A1 Human dbi/acbp-like protein |
02/19/1998 | WO1998006846A1 Human induced tumor protein |
02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
02/19/1998 | WO1998006843A1 Neuritin, a neurogene |
02/19/1998 | WO1998006842A1 Mammalian cell surface antigens; related reagents |
02/19/1998 | WO1998006841A2 Two human nsp-like proteins |
02/19/1998 | WO1998006840A1 Novel human glycoprotein |
02/19/1998 | WO1998006839A1 Cd44-like protein |
02/19/1998 | WO1998006838A1 Methods and means for modifying complement activation |
02/19/1998 | WO1998006837A1 Phenotypic conversion of drug-resistant bacteria to drug-sensitivity |
02/19/1998 | WO1998006830A1 Synthetic polynucleotides |
02/19/1998 | WO1998006826A1 Dendritic cells produced in serum-free culture |
02/19/1998 | WO1998006823A2 Cytokine-free culture of dendritic cells |
02/19/1998 | WO1998006753A2 P53 mutant |
02/19/1998 | WO1998006752A1 A leptin binding protein and its use in methods for diagnosing and treating abnormalities of the endogenous leptin pathway |
02/19/1998 | WO1998006751A1 Mcp-3, rantes and mip-1alpha receptor antagonists |
02/19/1998 | WO1998006749A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
02/19/1998 | WO1998006747A2 Uses for wnt polypeptides |
02/19/1998 | WO1998006745A1 Amino-lipopeptide antifungal agents |